```html

Nasal Herpes Simplex Infection – A Complete Medical Guide

Overview

Herpes simplex virus (HSV) infection of the nose, commonly called “nasal herpes simplex,” occurs when HSV‑1 or, less frequently, HSV‑2 infects the skin and mucous membranes of the nostrils, nasal septum, or surrounding facial tissues. The condition presents as painful vesicles or ulcers that can impair breathing, smell, and daily comfort.

While HSV is best known for causing oral “cold sores,” the virus can colonize any mucocutaneous site after primary exposure. Nasal involvement is less common than oral or genital disease, but it is not rare—studies estimate that 1–5 % of people with recurrent HSV‑1 infection will eventually develop nasal lesions at some point in their lives [1].

Who is affected? Almost anyone exposed to HSV can develop nasal infection, but certain groups are more frequently diagnosed:

• Children and adolescents – primary infection often occurs in the first two decades of life.
• Immunocompromised individuals (HIV, organ‑transplant recipients, chemotherapy patients).
• People with chronic nasal irritation (e.g., frequent nose‑picking, allergic rhinitis, habitual nasal spray use).
• Adults with a history of oral herpes who touch the nose after a breakout.

In the United States, about 50–80 % of adults are seropositive for HSV‑1 [2], making the virus one of the most prevalent human pathogens. Because most infections are asymptomatic or present as mild oral cold sores, nasal disease may go under‑reported.

Symptoms

Symptoms can appear 2–12 days after exposure (incubation period) and tend to recur in the same location. The clinical picture varies from mild irritation to painful ulceration.

Typical manifestations

• Vesicles or pustules – Small, fluid‑filled blisters on the nostril rim, septum, or adjacent skin. They often appear in clusters.
• Ulceration – Vesicles rupture, leaving shallow ulcers that may crust over.
• Burning, tingling, or itching – Known as the “prodrome” that precedes visible lesions.
• Redness (erythema) and swelling – Affected area may become inflamed, causing nasal congestion.
• Crusting or scabbing – As lesions heal, a yellow‑white crust may form.
• Odor – Secondary bacterial colonisation can cause a mild foul smell.

Associated systemic symptoms (more common in primary infection)

• Low‑grade fever
• Headache
• Generalized fatigue
• Enlarged lymph nodes (submandibular or cervical)

When symptoms differ

In immunocompromised patients, lesions can be larger, persistent, and may be accompanied by secondary bacterial infection (erythema, purulent discharge). Rarely, HSV can spread to deeper nasal structures, causing perichondritis or even osteomyelitis of the nasal bone.

Causes and Risk Factors

Viral etiology

Two herpes simplex viruses are implicated:

• HSV‑1 – Responsible for >90 % of nasal infections; transmitted primarily via oral‑to‑nasal contact or autoinoculation.
• HSV‑2 – Less common; usually acquired through genital contact and later spread to the nose by self‑inoculation.

How the virus reaches the nose

• Direct contact – Kissing, sharing utensils, or touching a cold sore then the nose.
• Autoinoculation – Rubbing a healing oral lesion onto the nostril.
• Hematogenous spread – Very rare; occurs during primary viremia in newborns.

Risk factors

• History of oral or genital herpes.
• Frequent nasal trauma (nose‑picking, nasal sprays, nasal packing, surgery).
• Allergic rhinitis or chronic sinusitis causing persistent irritation.
• Immunosuppression (HIV/AIDS, steroids, chemotherapy, organ transplant).
• Living in close‑quarters settings (college dorms, military barracks) where HSV spreads easily.

Diagnosis

Accurate diagnosis combines clinical assessment with laboratory confirmation, especially when lesions are atypical or the patient is immunocompromised.

Clinical evaluation

• Visual inspection – characteristic grouped vesicles progressing to ulcers.
• History – recent oral herpes, immunosuppression, or trauma to the nose.

Laboratory tests

• Polymerase chain reaction (PCR) – Detects HSV DNA from a swab; >95 % sensitivity.
• Viral culture – Gold standard historically but slower; useful when PCR unavailable.
• Direct fluorescent antibody (DFA) – Rapid (within hours) but less sensitive than PCR.
• Serology – Determines past exposure (IgG) vs. acute infection (IgM); not specific for nasal disease.

When to consider a biopsy

Persistent lesions (>4 weeks) that do not respond to antiviral therapy should be biopsied to rule out malignancy, granulomatous disease, or atypical infections.

Treatment Options

Therapy aims to shorten lesion duration, reduce pain, prevent complications, and decrease recurrence frequency.

Antiviral medications

Drug	Typical Dose for Nasal HSV	Duration
Acyclovir (Zovirax)	400 mg orally 5×/day	7–10 days
Valacyclovir (Valtrex)	1 g orally 2×/day	5–7 days
Famciclovir (Famvir)	500 mg orally 3×/day	7 days

For severe disease or immunocompromised patients, intravenous acyclovir (5 mg/kg every 8 h) may be required [3].

Topical agents

• Acyclovir cream 5 % – Applied 5×/day; modest benefit, mainly for mild cases.
• Penciclovir 1 % ointment – Used similarly; evidence specific to nasal mucosa is limited.

Adjunctive care

• Analgesics – Acetaminophen or ibuprofen for pain and fever.
• Topical anesthetic gel (e.g., lidocaine 2 %) – Provides short‑term comfort.
• Saline nasal irrigation – Keeps the area moist, reduces crusting and promotes healing.

When surgery is considered

Rarely, recurrent lesions cause significant tissue loss or structural deformity (e.g., nasal septum perforation). In such cases, an ENT surgeon may perform debridement, skin grafting, or reconstruction after infection has cleared.

Lifestyle modifications

• Avoid touching or picking lesions.
• Wash hands thoroughly after any contact with the nose or oral lesions.
• Limit use of intranasal steroids or vasoconstrictors during an active outbreak.

Living with Nasal Herpes Simplex Infection

Most people experience occasional recurrences rather than a constant problem. The following practical tips help manage daily life:

• Track triggers – Stress, sun exposure, hormonal changes, and fatigue often precede outbreaks. Keeping a simple diary can help anticipate and pre‑empt lesions.
• Initiate antiviral therapy early – Starting medication at the first tingling sensation (prodrome) can reduce lesion size by up to 70 % [4].
• Maintain nasal hygiene – Use isotonic saline sprays 2–3 times daily; avoid alcohol‑based products that dry the mucosa.
• Protect the skin – Apply a thin layer of petroleum jelly or a hypoallergenic moisturizer after cleaning to prevent cracking.
• Manage pain – Over‑the‑counter analgesics, cool compresses, or a topical lidocaine gel can ease discomfort during outbreaks.
• Communicate with partners – HSV is contagious; inform intimate partners, especially during active lesions, and consider using barrier protection (e.g., masks or facial shields during kissing).

Prevention

Because HSV remains in the body for life, prevention focuses on reducing transmission and trigger‑related reactivations.

Primary prevention (before infection)

• Avoid sharing personal items that touch the mouth or nose (towels, lip balm, nasal sprays).
• Practice good hand hygiene—wash hands with soap for ≥20 seconds after touching the face.
• Limit close contact (kissing, oral‑to‑nasal contact) with individuals who have active cold sores.
• Vaccines are currently under investigation but not yet available; stay informed about clinical trials.

Secondary prevention (preventing recurrences)

• Consider daily suppressive antiviral therapy (e.g., valacyclovir 500 mg once daily) if you have ≥4‑5 outbreaks per year [5].
• Use broad‑spectrum sunscreen on the nose to reduce UV‑triggered reactivation.
• Manage stress through regular exercise, meditation, or counseling.
• Control comorbid conditions (e.g., diabetes, HIV) that can lower immunity.
• Avoid nasal trauma—limit aggressive nose‑picking, and use gentle techniques when blowing the nose.

Complications

While most cases resolve without lasting effects, untreated or severe nasal HSV can lead to:

• Secondary bacterial infection – Often Staphylococcus aureus or Streptococcus spp.; may require antibiotics.
• Perichondritis – Inflammation of the cartilage surrounding the nose, causing pain, swelling, and potential cartilage damage.
• Nasal septum perforation – Rare; chronic ulceration can create a hole in the septum, leading to crusting, whistling sounds, and nasal obstruction.
• Scarring and cosmetic deformity – Persistent lesions may lead to fibrosis, retraction of the nostril or alar rim.
• Disseminated HSV – In severely immunocompromised patients, the virus can spread to the brain (HSV encephalitis) or eyes (herpes keratitis), both medical emergencies.

When to Seek Emergency Care

References

1. Whitley RJ, Kimberlin DW. Herpes Simplex Virus Infections. Lancet. 2020;395(10223):1618‑1629.
2. Centers for Disease Control and Prevention. HSV‑1 and HSV‑2 Epidemiology. Updated 2023. https://www.cdc.gov/std/herpes/stats.htm
3. American Academy of Otolaryngology–Head & Neck Surgery. Clinical Practice Guidelines: Management of HSV Infections of the Upper Aerodigestive Tract. 2022.
4. Mayo Clinic. Herpes simplex virus infection (cold sores). 2024. https://www.mayoclinic.org
5. Cleveland Clinic. Suppressive Therapy for Recurrent Herpes Simplex. 2023. https://my.clevelandclinic.org

```